Fifty percent of US GLP-1 users report shopping for clothes more often since starting the drugs, while 29% are buying accessories more frequently, according to a Dentsu report
Bring just to a boil and stir in the oats
Important safety considerations: Seek urgent same-day medical assessment via NHS 111 or A&E for severe abdominal pain (potential pancreatitis) and stop taking the medication pending review Report persistent nausea, vomiting, or signs of dehydration Be aware of increased hypoglycaemia risk if taking insulin or sulfonylureas (dose adjustments may be needed) Attend regular monitoring appointments for kidney function, diabetic retinopathy, and other parameters Discuss contraception if you are of childbearing potential, as GLP-1 receptor agonists are generally not recommended during pregnancy or breastfeeding [11] Report any suspected side effects via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk) Specific administration requirements vary by product
And we know in Massachusetts we are very proud of MassHealth, that started covering these drugs, weight loss drugs, since January 2024
Anyone who miscalculates concentration here is not off by 10 percent, they could be injecting a multiple of their intended dose